Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
141 hedge funds and large institutions have $1.75B invested in Amicus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 19 closing their positions.
143% more call options, than puts
Call options by funds: $31.4M | Put options by funds: $12.9M
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
46% more capital invested
Capital invested by funds: $1.2B → $1.75B (+$550M)
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
5% more funds holding
Funds holding: 134 → 141 (+7)
3.61% more ownership
Funds ownership: 118.25% → 121.86% (+3.6%)
0% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$56.5M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$24.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$11.4M |
| 4 |
Morgan Stanley
New York
|
+$9.02M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.07M |
| 2 |
GG
GCM Grosvenor
Chicago,
Illinois
|
-$8.28M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$8.19M |
| 4 |
Axa
Paris,
France
|
-$6.77M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.66M |
FOLD Hedge Fund Activity: Q2 2017 in Review
141 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2017, worth a combined $1.75B — up 46% from $1.2B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new FOLD positions and 19 closed out — a net gain of 9 holders — while 44 added to existing stakes and 44 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $56.5M. The largest seller was Point72 Asset Management, cutting an estimated $9.07M.
- 141 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2017, up from 134 in Q1 2017.
- Funds reported $1.75B of Amicus Therapeutics stock for Q2 2017, up 46% quarter-over-quarter.
- 28 funds opened new Amicus Therapeutics positions in Q2 2017 and 19 closed out, a net change of +9 holders.
- The largest Amicus Therapeutics buyer in Q2 2017 was Janus Henderson Group, an estimated $56.5M added.
- The largest Amicus Therapeutics seller in Q2 2017 was Point72 Asset Management, an estimated $9.07M sold.
Based on aggregated 13F filings for Q2 2017.